Ironwood Pharmaceuti (IRWD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Sales | 94,396 | 74,877 | 117,553 | 113,739 | 107,382 |
| Gross Profit | 94,396 | 74,877 | 117,553 | 113,739 | 107,382 |
| Operating Expenses | 69,419 | 63,857 | 79,964 | 73,716 | 1,190,521 |
| Operating Income | 24,977 | 11,020 | 37,589 | 40,023 | -1,083,139 |
| Interest Expense | 7,470 | 7,231 | 8,423 | 9,839 | 1,840 |
| Other Income | 1,369 | 1,169 | 1,194 | 1,748 | 8,757 |
| Pre-tax Income | 18,876 | 4,958 | 30,360 | 31,932 | -1,076,222 |
| Income Tax | 19,736 | 9,120 | 32,105 | 17,982 | 13,256 |
| Net Income Continuous | -860 | -4,162 | -1,745 | 13,950 | -1,089,478 |
| Minority Interests | N/A | N/A | -658 | -1,371 | -27,291 |
| Net Income | $-860 | $-4,162 | $-1,087 | $15,321 | $-1,062,187 |
| EPS Basic Total Ops | -0.01 | -0.03 | -0.01 | 0.10 | -6.84 |
| EPS Basic Continuous Ops | -0.01 | -0.03 | -0.01 | 0.09 | -7.01 |
| EPS Diluted Total Ops | -0.01 | -0.03 | 0.05 | 0.09 | -6.84 |
| EPS Diluted Continuous Ops | -0.01 | -0.03 | 0.06 | 0.07 | -7.01 |
| EPS Diluted Before Non-Recurring Items | 0.00 | -0.02 | 0.00 | N/A | N/A |
| EBITDA(a) | $25,483 | $11,533 | $38,101 | $40,530 | $-1,082,869 |